Woodline Partners’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.6M Buy
1,815,221
+847,544
+88% +$5.9M 0.04% 473
2025
Q4
$6.81M Buy
+967,677
New +$5.84M 0.03% 557
2025
Q1
Sell
-632,301
Closed -$4.66M 977
2024
Q4
$4.66M Sell
632,301
-691,089
-52% -$4.96M 0.03% 497
2024
Q3
$9.26M Buy
+1,323,390
New +$7.95M 0.08% 314
2021
Q3
Sell
-273,207
Closed -$7.61M 717
2021
Q2
$7.61M Buy
+273,207
New +$7.22M 0.14% 172

Other funds holding LFST

Woodline Partners's LFST Position: Q1 2026 in Review

Woodline Partners increased its Lifestance Health (LFST) stake by 88% in Q1 2026, buying an estimated $5.9M and bringing the position to 1,815,221 shares worth $11.6M. The position accounts for 0.04% of the portfolio, ranked #473.

Woodline Partners first reported a position in LFST in Q2 2021 and has held it in 5 quarters since. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Woodline Partners held 1,815,221 shares of Lifestance Health worth $11.6M as of Q1 2026.
  • Woodline Partners bought 847,544 Lifestance Health shares in Q1 2026, an estimated $5.9M.
  • Lifestance Health made up 0.04% of Woodline Partners's portfolio in Q1 2026, its #473 holding.
  • Woodline Partners first reported a position in Lifestance Health in Q2 2021 and has held it in 5 quarters since.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.